NasdaqGS - Nasdaq Real Time Price USD
Zymeworks Inc. (ZYME)
12.16
+0.41
+(3.49%)
At close: 4:00:01 PM EDT
12.16
0.00
(0.00%)
After hours: 4:30:40 PM EDT
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| ASTLE CHRISTOPHER Chief Financial Officer | Sale | Jan 8, 2024 | 6,503 |
| ECOR1 CAPITAL, L.L.C. Beneficial Owner of more than 10% of a Class of Security | Purchase | Apr 17, 2025 | -- |
| GALBRAITH KENNETH HARRY Chief Executive Officer | Conversion of Exercise of derivative security | Jan 6, 2025 | 80,803 |
| MOORE PAUL ANDREW Officer | Conversion of Exercise of derivative security | Jan 6, 2025 | 23,333 |
| SMITH JEFFREY T L MD, FRCP Officer | Conversion of Exercise of derivative security | Jan 6, 2025 | 8,890 |
Related Tickers
ANAB AnaptysBio, Inc.
21.58
+4.66%
BCYC Bicycle Therapeutics plc
8.73
+16.24%
CGEM Cullinan Therapeutics, Inc.
8.37
+3.33%
JAZZ Jazz Pharmaceuticals plc
103.38
+3.03%
CNTA Centessa Pharmaceuticals plc
12.67
+4.28%
PRTA Prothena Corporation plc
9.54
+2.58%
SNDX Syndax Pharmaceuticals, Inc.
12.92
+8.30%
IGMS IGM Biosciences, Inc.
1.4600
+14.06%
VALN Valneva SE
6.81
+1.34%
DAWN Day One Biopharmaceuticals, Inc.
7.33
+2.66%